000			03491nam a22003495i 4500
001			233079
003			ES-VaUE
005			20221220020437.0
007			cr nn 008mamaa
008			181025s2018 xxu| s |||| 0|eng d
020			_a9781493988181
024	7		_a10.1007/978-1-4939-8818-1 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
245	1	0	_aEvidence-Based Pharmacovigilance _bClinical and Quantitative Aspects _cedited by Andrew Bate.
250			_a1st edition 2018
264		1	_aNew York, NY _bSpringer International Publishing _c2018
300			_a1 recurso en línea (XV, 275 páginas) _b36 ilustraciones, 27 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aMethods in Pharmacology and Toxicology _x1940-6053
505	0		_aCongenital Malformations -- Pharmacovigilance and the Eye -- Pharmacovigilance of Herbal and Traditional Medicines -- Pediatric Pharmacovigilance: Current Practice and Future Perspectives -- Detecting Safety Issues in Clinical Trials -- Developments and Future Directions of Prescription-Based Observational Cohort Pharmacovigilance -- Electronic Health Record, Transactional Insurance Claims, and Distributed Databases in Pharmacovigilance -- Patient Registries for Safetyness -- Patient-Reported Outcomes in Pharmacovigilance -- Evidence-Based Pharmacovigilance for Medicines Used in Public Health Programs in Africa -- Pharmacoepidemiological Approaches for Population-Based Hypothesis Testing -- Risk Management and Minimization -- Benefit-Risk Assessment in Pharmacovigilance -- Concluding Thoughts.
520			_aThis book examines insights into the latest thinking and core concepts in areas of key methodological endeavor in Pharmacovigilance (PV), which strives to ever more effectively protect patients from harm caused by the medicines they need. Each book chapter tends to have a clear quantitative or clinical slant and an aim to provide an overview of methodological insights within a specific topic, while also providing a perspective on how the area is anticipated to develop in the future. Quantitative chapters focus more on statistical and epidemiological strategies and the thinking that underpins core developments in Pharmacovigilance, whereas clinical chapters focus on clinical methods for detecting hypotheses for and determining side effects of medicinal products as well as misdiagnosis pitfalls. Examples of areas of importance include signal detection, risk management, and risk benefit assessment. Vital and authoritative, Evidence-Based Pharmacovigilance: Clinical and Quantitative Aspects aims to provide readers with a sense of the advances that have occurred in pharmacovigilance methods and approaches, as well as inspiration and motivation to advance the field of pharmacovigilance with a strong sense that there is much more work to be done in ensuring the safe use of medications by patients.
700	1		_aBate, Andrew _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9781493988167
776	0	8	_iPrinted edition: _z9781493988174
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-4939-8818-1 _z(usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
988			_aSpringer_Protocols_2018
999			_c233079 _d233079